Pfizer’s RSV vaccine shows benefit in immuno-compromised adults in study Reuters Aug 12, 2024 In a late-stage study, Pfizer’s Abrysvo vaccine generated robust antibodies against RSV-A and RSV-B in immunocompromised adults,…
